A Study to Evaluate Post-discharge Early Assessment with a Video Visit

Overview

About this study

The purpose of this study is to evaluate whether a video visit with an advanced practice provider (APP (Nurse practitioner or Physician assistant) within 7 days after discharge from Hospital Internal Medicine services at Saint Marys Hospital will increase patient adherence with medication, self-management, and home support post-hospital discharge (primary outcome). We will also evaluate subsequent 7- and 30- day emergency department visits and hospital re-admissions (secondary outcome). Patients enrolled in the study will undergo 1:1 randomization: video-visit + usual care (intervention arm) and usual care (control arm).  Participants in each arm will participate in a telephone survey 4-6 days after hospital discharge reviewing discharge medication and self-management.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients, ≥ 18 years of age.
  • Patients discharged from a Hospital Internal Medicine service at Saint Marys Hospital to patient's home or assisted living facility.
  • Patients or their legally authorized representative provides consent to participate in the study.

Exclusion Criteria: 

  • Patients discharged from Hospital Service Meds 1-4 and Med 17.
  • Patient discharged with Care Transitions Program, or to Hospice, skilled nursing facility (SNF) or long-term acute care (LTAC) facility.
  • Post-procedure patients (i.e., elective hospital admission for planned intervention or procedure).
  • Patient/legally authorized representative is Non-English speaking.
  • Patient leaves the hospital Against Medical Advice (AMA).
  • No access to mobile technology/laptop/computer for post-discharge follow-up.
  • Patient with an active diagnosis Covid-19 infection.
  • Patients with a scheduled re-admission for a procedure, chemotherapy, or other treatment.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Chandrasagar Dugani, M.D., Ph.D.

Open for enrollment

Contact information:

Chandrasagar Dugani M.D., Ph.D.

(507) 255-8043

Dugani.Chandrasagar@mayo.edu

Austin, Minn.

Mayo Clinic principal investigator

Anne Liwonjo, M.D.

Open for enrollment

Contact information:

Chandrasagar Dugani M.D., Ph.D.

Dugani.Chandrasagar@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20502319

Mayo Clinic Footer